KU Hematology & Medical Oncology Review 2019

 

Genitourinary
11:59

KU Hematology & Medical Oncology Review 2019

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer and Enfortumab in Metastatic Bladder Cancer

FEATURING Rahul Parikh
  • 839 views
  • August 22, 2019
  • 4
11:41

KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal Cell Carcinoma

FEATURING Rahul Parikh
  • 178 views
  • August 22, 2019